Apoquel (oclacitinib tablet), 5.4 mg

Supplied By: Zoetis (10021175)


SKU
085736


Unit of
Measure
100 Count


Pack
Type
Bottle


Case
Qty
48

{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Dec- 2025 Nov- 2025 Oct- 2025 Sep- 2025 Aug- 2025 Jul- 2025 Jun- 2025 May- 2025 Apr- 2025 Mar- 2025 Feb- 2025 Jan- 2025 Dec- 2024
{{purchaseHistoryItem}}


SKU
085736


Size
100 Count

Case
Qty
48

Purchase History

Dec- 2025 {{productPurchaseHistory['085736'][0]}} May- 2025 {{productPurchaseHistory['085736'][0+7]}}
Nov- 2025 {{productPurchaseHistory['085736'][1]}} Apr- 2025 {{productPurchaseHistory['085736'][1+7]}}
Oct- 2025 {{productPurchaseHistory['085736'][2]}} Mar- 2025 {{productPurchaseHistory['085736'][2+7]}}
Sep- 2025 {{productPurchaseHistory['085736'][3]}} Feb- 2025 {{productPurchaseHistory['085736'][3+7]}}
Aug- 2025 {{productPurchaseHistory['085736'][4]}} Jan- 2025 {{productPurchaseHistory['085736'][4+7]}}
Jul- 2025 {{productPurchaseHistory['085736'][5]}} Dec- 2024 {{productPurchaseHistory['085736'][5+7]}}
Jun- 2025 {{productPurchaseHistory['085736'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

Apoquel® is indicated for the control of pruritus associated with allergic dermatitis and atopic dermatitis in dogs 12 months of age and older.*

*Source: https://www.zoetispetcare.com/products/apoquel/tablet

Features & Benefits

  • Rapid, powerful allergic itch relief that starts in 4 hours
  • Significant reduction of inflammation due to allergic dermatitis
  • Start-and-stop itch control that can be used during diagnostic trials
  • Management of pruritic flares
  • Also available in a highly palatable, treat-like chewable formulation, which may help eliminate stress and enhance dosing compliance
  • Active ingredient: Oclacitinib

Active Ingredients

Oclacitinib